
Asarfi Hospital (ASARFI) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
338.9M
Gross Profit
264.0M
77.89%
Operating Income
18.2M
5.38%
Net Income
35.9M
10.59%
Balance Sheet Metrics
Total Assets
1.6B
Total Liabilities
829.0M
Shareholders Equity
809.8M
Debt to Equity
1.02
Cash Flow Metrics
Operating Cash Flow
-93.1M
Free Cash Flow
-106.8M
Revenue & Profitability Trend
Asarfi Hospital Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 1.2B | 844.0M | 707.0M | 652.1M | 541.2M |
Cost of Goods Sold | 278.6M | 203.2M | 200.3M | 256.8M | 226.8M |
Gross Profit | 927.1M | 640.8M | 506.7M | 395.4M | 314.4M |
Gross Margin % | 76.9% | 75.9% | 71.7% | 60.6% | 58.1% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 178.8M | 130.2M | 104.4M | 81.6M |
Other Operating Expenses | 505.3M | 339.0M | 125.7M | 93.8M | 68.6M |
Total Operating Expenses | 505.3M | 517.8M | 255.9M | 198.2M | 150.2M |
Operating Income | 108.7M | 72.6M | 99.0M | 74.4M | 52.8M |
Operating Margin % | 9.0% | 8.6% | 14.0% | 11.4% | 9.8% |
Non-Operating Items | |||||
Interest Income | - | 7.0M | 2.2M | 2.9M | 1.7M |
Interest Expense | 40.8M | 26.9M | 8.7M | 2.3M | 4.7M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 143.1M | 62.4M | 108.9M | 77.2M | 47.7M |
Income Tax | 37.3M | 20.8M | 28.7M | 19.9M | 12.4M |
Effective Tax Rate % | 26.1% | 33.3% | 26.4% | 25.8% | 26.0% |
Net Income | 105.8M | 41.6M | 80.2M | 57.3M | 35.3M |
Net Margin % | 8.8% | 4.9% | 11.3% | 8.8% | 6.5% |
Key Metrics | |||||
EBITDA | 310.7M | 177.2M | 156.3M | 112.9M | 83.1M |
EPS (Basic) | - | ₹2.31 | ₹4.07 | ₹2.91 | ₹1.80 |
EPS (Diluted) | - | ₹2.31 | ₹4.07 | ₹2.91 | ₹1.80 |
Basic Shares Outstanding | - | 18015584 | 19677300 | 19677300 | 19677300 |
Diluted Shares Outstanding | - | 18015584 | 19677300 | 19677300 | 19677300 |
Income Statement Trend
Asarfi Hospital Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 14.3M | 176.0M | 85.2M | 137.2M | 67.5M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 398.0M | 242.6M | 169.3M | 53.3M | 21.0M |
Inventory | 22.8M | 18.0M | 14.2M | 10.9M | 8.2M |
Other Current Assets | 141.1M | - | - | - | - |
Total Current Assets | 584.8M | 467.5M | 365.1M | 220.8M | 96.9M |
Non-Current Assets | |||||
Property, Plant & Equipment | 1.0B | 0 | 0 | 0 | 0 |
Goodwill | - | - | 0 | 0 | 0 |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 16.4M | -1.0K | -1.0K | -1.0K | -1.0K |
Total Non-Current Assets | 1.1B | 1.1B | 569.2M | 406.2M | 276.1M |
Total Assets | 1.6B | 1.5B | 934.3M | 627.0M | 372.9M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 130.4M | 248.6M | 49.9M | 24.0M | 14.1M |
Short-term Debt | 147.3M | 115.9M | 64.1M | 56.5M | 46.3M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 76.7M | - | 1.0K | 1.0K | - |
Total Current Liabilities | 410.4M | 414.8M | 195.9M | 147.6M | 86.3M |
Non-Current Liabilities | |||||
Long-term Debt | 338.3M | 203.2M | 107.9M | 59.9M | 25.0M |
Deferred Tax Liabilities | 33.7M | 27.2M | 8.1M | 7.2M | 7.5M |
Other Non-Current Liabilities | 34.6M | - | -1.0K | -1.0K | - |
Total Non-Current Liabilities | 418.6M | 422.0M | 319.9M | 253.1M | 117.6M |
Total Liabilities | 829.0M | 836.8M | 515.8M | 400.8M | 204.0M |
Equity | |||||
Common Stock | 196.8M | 196.8M | 145.0M | 12.5M | 12.5M |
Retained Earnings | - | 247.9M | 193.3M | 175.6M | 118.4M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 809.8M | 704.1M | 418.4M | 226.3M | 169.0M |
Key Metrics | |||||
Total Debt | 485.6M | 319.1M | 172.0M | 116.3M | 71.3M |
Working Capital | 174.5M | 52.7M | 169.2M | 73.2M | 10.5M |
Balance Sheet Composition
Asarfi Hospital Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 105.8M | 41.6M | 108.9M | 77.2M | 47.7M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -181.7M | -101.2M | -200.2M | -13.3M | 37.5M |
Operating Cash Flow | -76.5M | -39.7M | -80.1M | 67.9M | 89.9M |
Investing Activities | |||||
Capital Expenditures | -105.0M | -460.7M | -201.4M | -195.2M | -83.6M |
Acquisitions | - | - | - | - | - |
Investment Purchases | 0 | -96.9M | 0 | -71.0M | -43.9M |
Investment Sales | 18.3M | 0 | 63.1M | 0 | 0 |
Investing Cash Flow | -85.9M | -562.5M | -138.4M | -266.1M | -127.5M |
Financing Activities | |||||
Share Repurchases | 0 | 0 | -62.5M | 0 | 0 |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 220.4M | 116.8M | - | - | - |
Debt Repayment | -55.3M | -21.4M | - | - | - |
Financing Cash Flow | 158.0M | 391.0M | 112.0M | 0 | 0 |
Free Cash Flow | -161.4M | -200.0M | -222.1M | -102.5M | 19.3M |
Net Change in Cash | -4.4M | -211.2M | -106.5M | -198.2M | -37.6M |
Cash Flow Trend
Asarfi Hospital Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
24.44
Price to Book
3.06
Price to Sales
1.97
Profitability Ratios
Profit Margin
8.83%
Operating Margin
14.60%
Return on Equity
14.56%
Return on Assets
5.28%
Financial Health
Current Ratio
1.21
Debt to Equity
55.65
Per Share Data
EPS (TTM)
₹5.37
Book Value per Share
₹42.85
Revenue per Share
₹66.41
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
asarfi | 2.6B | 24.44 | 3.06 | 14.56% | 8.83% | 55.65 |
Max Healthcare | 1.2T | 115.26 | 13.09 | 12.10% | 15.31% | 32.09 |
Apollo Hospitals | 1.0T | 72.09 | 12.70 | 18.85% | 6.63% | 90.89 |
Indraprastha Medical | 42.7B | 26.50 | 7.15 | 26.98% | 12.21% | 5.49 |
Shalby | 21.8B | 1,126.78 | 1.99 | 0.19% | 0.57% | 9.69 |
Dr. Agarwal's Eye | 20.7B | 37.83 | 9.87 | 29.80% | 13.76% | 158.94 |
Financial data is updated regularly. All figures are in the company's reporting currency.